A member of a new class of antiretroviral drugs is safe and effective for patients beginning treatment against HIV, according to researchers who have completed a two-year multisite phase III clinical trial comparing it with standard antiretroviral drugs.
Read more ...
Sunday, August 9, 2009
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment